Latest News
- November 18, 2025ANDA application for Bimatoprost ophthalmic solution received Marketing Authorization from the USFDA!
- November 12, 2025ANDA application for Risperidone extended-release injectable suspension has received Marketing Authorization from the USFDA!
- October 30, 2025Accelerating Clinical Research!
- September 12, 2025Join CBCC at CPHI Frankfurt 2025
- August 08, 2025International Publication of Phase II clinical Trial
Attending Immuno-Oncology 360°
We are excited to attend Immuno-Oncology 360°
Date: 27 – 29 February, 2024
Location: Brooklyn, NY
Meet with our team member Ajit Upadhyaya
To schedule business appointment with him, please email us at: ajit.upadhyaya@cbcc.global
For more information about this conference, please visit: https://io360summit.com/
We will be attending below upcoming events:
1. The 17th ISCR Annual Conference 2024 (1 – 3 February 2024, Hyderabad, India)
2. Bio Asia 2024 (26 – 28 February 2024, Hyderabad, India)
3. Immuno-Oncology 360 (27 – 29 February 2024, New York)
4. DCAT Week (18 – 21 March 2024, New York)
We will be glad to schedule an appointment with you to discuss your upcoming drug development plan and help you bring the treatment to market faster.
For business appointments please email us at bd@cbcc.global
CBCC Global Research: CHANGING LIVES THROUGH HOPE AND INNOVATION